AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nexien BioPharma, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.01
Market Cap
7.08K
AVG Volume
332
Trailing/Forward PE
-0.03/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (USD) · TTM
-25B025B50B75B100B23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
NXEN Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
25 Q3-188.08K
25 Q2-211.15K
25 Q1-196.2K
24 Q4-239.11K
24 Q3-246.18K
24 Q282.25B
24 Q182.25B
23 Q482.25B
23 Q382.25B
23 Q2-472.47K
Operating Income (USD) · TTM
-400K-300K-200K-100K023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
NXEN Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
25 Q3-118.32K
25 Q2-119.97K
25 Q1-109.38K
24 Q4-155.66K
24 Q3-157.26K
24 Q2-210.69K
24 Q1-270.29K
23 Q4-282.61K
23 Q3-287.88K
23 Q2-382.5K
EBITDA (USD) · TTM
-80K-60K-40K-20K020K23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
NXEN EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
25 Q3-64.28K
25 Q2-64.28K
25 Q1-77.71K
24 Q4-77.71K
24 Q3-13.42K
24 Q2-13.42K
24 Q10
23 Q40
23 Q30
23 Q2403
Cash Flows (USD) · TTM
-100K-75K-50K-25K023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
NXEN Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
25 Q3-61.78K
25 Q2-69.71K
25 Q1-56.51K
24 Q4-64.36K
24 Q3-72.54K
24 Q2-66.37K
24 Q1-83.08K
23 Q4-81.75K
23 Q3-86.01K
23 Q2-92.95K
EPS (USD) · TTM
-0.01-0.01-0-0023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
NXEN EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
25 Q3-0
25 Q2-0
25 Q1-0
24 Q4-0
24 Q3-0
24 Q2-0
24 Q1-0.01
23 Q4-0.01
23 Q3-0.01
23 Q2-0.01
Expenses (USD) · TTM
-100K0100K200K300K400KR&DSG&ACapex23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
NXEN Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
25 Q3118.32K
25 Q2119.97K
25 Q1109.37K
24 Q4155.66K
24 Q3157.26K
24 Q2210.69K
24 Q1270.29K
23 Q4282.61K
23 Q3287.88K
23 Q2382.9K
Shares Outstanding · TTM
-60K-40K-20K023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
NXEN Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
25 Q3-49.2K
25 Q2-49.2K
25 Q1-49.2K
24 Q4-49.23K
24 Q3-85
24 Q2-135
24 Q1-185
23 Q4-200
23 Q3-91
23 Q2-186
Employee Count
012342018
NXEN Employee Count by quarter
PeriodEmployee Count
20183
PE Ratio
00000med 0Jun 23Aug 23Sep 23Nov 23Jan 24Mar 24May 24
NXEN PE Ratio by quarter
PeriodPE Ratio
May 240
May 240
Apr 240
Apr 240
Apr 240
Apr 240
Mar 240
Mar 240
Mar 240
Mar 240
Mar 240
Feb 240
Feb 240
Feb 240
Feb 240
Jan 240
Jan 240
Jan 240
Jan 240
Dec 230
Dec 230
Dec 230
Dec 230
Dec 230
Nov 230
Nov 230
Nov 230
Nov 230
Oct 230
Oct 230
Oct 230
Oct 230
Sep 230
Sep 230
Sep 230
Sep 230
Sep 230
Aug 230
Aug 230
Aug 230
Aug 230
Jul 230
Jul 230
Jul 230
Jul 230
Jun 230
Jun 230
Jun 230
Jun 230
Jun 230
May 230
May 230
Free Cash Flow Yield
-1000%-750%-500%-250%0%med -14.55%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NXEN Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-872.91%
Sep 26-872.91%
Aug 26-872.91%
Aug 26-872.91%
Aug 26-872.91%
Aug 26-872.91%
Jul 26-872.91%
Jul 26-872.91%
Jul 26-872.91%
Jul 26-872.91%
Jul 26-872.91%
Jun 26-872.91%
Jun 26-872.91%
Jun 26-872.91%
Jun 26-872.91%
May 26-872.91%
May 26-872.91%
May 26-872.91%
May 26-872.91%
May 26-872.91%
Apr 26-872.91%
Apr 26-872.91%
Apr 26-872.91%
Apr 26-872.91%
Mar 26-872.91%
Mar 26-872.91%
Mar 26-872.91%
Mar 26-872.91%
Feb 26-872.91%
Feb 26-872.91%
Feb 26-872.91%
Feb 26-872.91%
Jan 26-872.91%
Jan 26-872.91%
Jan 26-872.91%
Jan 26-872.91%
Jan 26-872.91%
Dec 25-872.91%
Dec 25-872.91%
Dec 25-872.91%
Dec 25-872.91%
Nov 25-872.91%
Nov 25-872.91%
Nov 25-872.91%
Nov 25-48.5%
Oct 25-7.27%
Oct 25-7.27%
Oct 25-7.27%
Oct 25-7.27%
Oct 25-7.27%
Sep 25-7.27%
Sep 25-14.55%
Sep 25-7.27%
Sep 25-7.34%
Aug 25-6.71%
Aug 25-87.29%
Aug 25-14.55%
Aug 25-14.55%
Aug 25-14.55%
Jul 25-14.55%
Jul 25-14.55%
Jul 25-14.55%
Jul 25-12.47%
Jun 25-14.55%
Jun 25-9.7%
Jun 25-14.55%
Jun 25-5.82%
May 25-8.73%
May 25-8.73%
May 25-8.73%
May 25-9.85%
May 25-10.16%
Apr 25-10.37%
Apr 25-10.95%
Apr 25-10.95%
Apr 25-7.04%
Mar 25-9.85%
Mar 25-7.04%
Mar 25-7.04%
Mar 25-7.04%
Feb 25-14.07%
Feb 25-14.07%
Feb 25-14.07%
Feb 25-11.45%
Jan 25-13.36%
Jan 25-13.36%
Jan 25-7.29%
Jan 25-7.29%
Jan 25-5.01%
Dec 24-14.32%
Dec 24-13.36%
Dec 24-14.58%
Dec 24-4.22%
Nov 24-5.69%
Nov 24-4.01%
Nov 24-7.73%
Nov 24-7.18%
Nov 24-2.03%
Oct 24-2.14%
Oct 24-2.28%
EV/EBITDA
02000400060008000med 4210.97Mar 22May 22Aug 22Oct 22Dec 22Mar 23May 23
NXEN EV/EBITDA by quarter
PeriodEV/EBITDA
May 236579.58
May 236502.77
Apr 235734.59
Apr 234966.41
Apr 234966.41
Apr 234966.41
Mar 234966.41
Mar 235542.55
Mar 234582.32
Mar 235504.14
Mar 236410.59
Feb 235619.36
Feb 235872.86
Feb 235135.41
Feb 232448.04
Jan 232814.89
Jan 232753.75
Jan 232714.35
Jan 233429.71
Dec 224098.88
Dec 223528.22
Dec 224160.02
Dec 224173.61
Dec 224248.34
Nov 222760.54
Nov 222760.54
Nov 222760.54
Nov 222673.65
Oct 223066.32
Oct 222820.07
Oct 223202.09
Oct 224696.89
Sep 224463.96
Sep 224307.67
Sep 224128.63
Sep 224379.28
Sep 226062.19
Aug 224164.44
Aug 225471.38
Aug 223734.76
Aug 224504.6
Jul 224558.31
Jul 224486.7
Jul 224916.38
Jul 224021.21
Jul 225281.61
Jun 224486.7
Jun 224934.28
Jun 224665.73
Jun 225346.06
May 225163.45
May 224665.73
May 224486.7
May 2216.77
Apr 2216
Apr 2217.28
Apr 2237.29
Apr 2225.75
Apr 2215.46
Mar 2211.38
Mar 228.84
Mar 2211.91
Mar 2211.91
Feb 2212.65
Feb 2212.78
Feb 2212.88
Price to Book
0200400600med 26.14Sep 19Dec 19Apr 20Jul 20Mar 21Jun 21Oct 21
NXEN Price to Book by quarter
PeriodPrice to Book
Oct 21209.09
Oct 21188.66
Sep 21237.49
Sep 21225.55
Sep 21220.9
Sep 21203.66
Aug 21212.28
Aug 21218.78
Aug 21185.74
Aug 21185.74
Jul 21214.93
Jul 21185.74
Jul 21201.93
Jul 21225.55
Jul 21344.95
Jun 21185.48
Jun 21265.08
Jun 21289.23
Jun 21265.35
May 21261.24
May 21225.55
May 21264.82
May 21360.34
Apr 21258.35
Apr 21338.79
Apr 21362.86
Apr 21457.98
Apr 21290.99
Mar 21291.23
Mar 21277.37
Mar 21385.17
Mar 21435.38
Feb 21375.78
Feb 21361.68
Feb 21326.46
Sep 2034.18
Sep 2055.26
Sep 2053.87
Sep 2043.58
Aug 2039.81
Aug 2042.7
Aug 2051.22
Aug 2046.15
Jul 2051.28
Jul 2061.22
Jul 2079.76
Jul 2079.19
Jul 2027.75
Jun 2024.01
Jun 2028.37
Jun 2010.54
Jun 205.27
May 209.12
May 2012.68
May 2017.43
May 2013.69
May 2026.04
Apr 2017.62
Apr 2018.05
Apr 2015.88
Apr 2016.11
Mar 2013.08
Mar 2020.19
Mar 2015.56
Mar 2013.04
Feb 2014.72
Feb 2021.03
Feb 2022.71
Feb 2011.86
Jan 2014.24
Jan 2011
Jan 2018.69
Jan 2019.28
Jan 2019.28
Dec 1914.44
Dec 1913.75
Dec 1910.27
Dec 1921.68
Nov 1910.82
Nov 1917.11
Nov 1926.24
Nov 1918.08
Nov 1916.1
Oct 1910.09
Oct 1918.1
Oct 1915.57
Oct 1918.46
Sep 196.53
Sep 196.53
Sep 196.63
Sep 195.74
Aug 194.7
Aug 197.18
Aug 197.18
Aug 197.18
Aug 197.18
Jul 197.18
Jul 197.18
Jul 196.82
Jul 196.46
Nexien BioPharma, Inc.
NXEN
Stockpicker

Video analysis: NXEN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.